Team:Paris Bettencourt/Notebook/Trojan Horse/Friday 28th June

From 2013.igem.org

(Difference between revisions)
Line 1: Line 1:
 +
<html>
<div id"container">
<div id"container">
<div id="noteimg">
<div id="noteimg">
-
<html>
+
 
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse">
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse">
<img src="https://static.igem.org/mediawiki/2013/0/00/PB_Trojan_Horse_logo.png" height="30px" width="30px">
<img src="https://static.igem.org/mediawiki/2013/0/00/PB_Trojan_Horse_logo.png" height="30px" width="30px">
Line 7: Line 8:
</div>
</div>
<div id="notetwit">
<div id="notetwit">
-
<html>
 
<b> Add here your twit </b></br>
<b> Add here your twit </b></br>
 +
</div><div class"clear"></div></div>
</html>
</html>
-
</div><div class"clear"></div></div>
 
-
<div >
 
<div class="FU_note">
<div class="FU_note">
<html>
<html>

Revision as of 09:32, 29 July 2013

</div>

Add here your twit </br>

</div>

</html>

sRNA design

sRNA Design

Red sequences:

pACYCDuet-1 (CmR) : ATATCCAGTGATTTTTTTCTCCAT
pCOLADuet-1 (KanR) : CGTTTCCCGTTGAATATGGCTCAT

We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid litmus28i.